Metamark Genetics, Inc. — Form D
Metamark Genetics, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2010-07-09. The offering totals $42.1M, of which $22.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-07-09
- Form: D
- Accession: 0001460604-10-000001
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $42.1M
- Amount sold: $22.1M
- Remaining: $20.0M
- Investors: 3
- Date of first sale: 2010-07-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-144637
Issuer
- Name: Metamark Genetics, Inc.
- CIK: 0001460604
- Entity type: Corporation
- Jurisdiction: DE
- Incorporated: 2007
- Address: 103 CARNEGIE CENTER, PRINCETON, NJ, 08540
- Phone: 609-203-5118
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Lynda E Chin | Director | Naples, FL |
| Kenneth E Weg | Executive Officer | Natick, MA |
| Lynda Chin | Director | Houston, TX |
| Raju Kucherlapati | Director | Houston, TX |
| Mansoor Raza Mirza | Director | Newton, MA |
| Gregory C Critchfield | Director | Salt Lake City, UT |
| MICHAEL C KAUFFMAN | Director | NEEDHAM, MA |
| Norman C Selby | Director | Cambridge, MA |
| Kenneth E Weg | Director | Natick, MA |
| Raju E Kucherlapati | Director | Cambridge, MA |
| David E Cordo | Executive Officer | Cambridge, MA |
Other filings by this issuer (2)
More